Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoInstead, the Street is closely watching the adult RSV vaccine, which hit the market at the same time...
Merck wins U.S. approval for pneumonia vaccine to rival Pfizer’s
Crain's New York Business· 6 days agoCapvaxive has the potential to become the preferred vaccine given studies have shown it protects...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agoShares continued to climb, hitting a recent intraday high at 23.86 on June 6. Shares now have a top...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 5 days agoFor them, it has the virtue of being suggestive and unverifiable; with nearly 700 million doses of...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoMeanwhile, Pfizer began testing its pandemic vaccine last year. The company also just unveiled...
7 Dividend Stocks to Buy Now: June 2024
InvestorPlace· 8 hours agoThese dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...